• search

Factory to produce nuclear medicine for cancer inaugurated in Noida

Written by: Staff
|

New Delhi, Mar 20 (UNI) Belgium's Minister for Economy, Employment and Foreign Trade Jean-Claude today inaugurated a new factory producing nuclear medicine required for early detection of cancer and its treatment.

The factory of IBA Molecular Imaging India Ltd, a joint venture of IBA and New Merchants International, is the first such nuclear medicine factory in the private sector in and around Delhi National Capital Region.

The medical cyclotrone in the factory would produce radio isotopes which are required for radio-therapy of cancer patients. These radio isotopes go through a synthesis process and are then converted to radio pharmaceuticals. The most important isotope is F18 which is converted to FDG or Fluro-De Oxy Glucose as a radiopharmaceutical.

FDG is then delivered to hospitals and imaging centres where they are injected into a patient's body who is then scanned by PET camera to detect cancer.

''The new facility will be a boon for cancer patients for Delhi and the nearby region. The syringes with FDG will be delivered to hospitals and imaging centres in Delhi and nearby regions which can be done in real time now due to the proximity of the facility,'' said Mr Vincent De Rudder, Pharma Engineering EMEAA of IBA.

The cost of FDG would reduce due to the manufacturing taking place here, said Mr Fazal Manekia, Director NMI.

IBA, which is a world leader in manufacture of cyclotrons and operates them, said it was also planning to start operations in Bangalore and Mumbai.

UNI AJ SD DB1907

For Daily Alerts

For Breaking News from Oneindia
Get instant news updates throughout the day.

Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more